S H KELKAR & CO. | TATVA CHINTAN PHARMA | S H KELKAR & CO./ TATVA CHINTAN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 31.2 | 77.0 | 40.6% | View Chart |
P/BV | x | 2.7 | 5.6 | 47.5% | View Chart |
Dividend Yield | % | 1.0 | 0.2 | 602.1% |
S H KELKAR & CO. TATVA CHINTAN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
S H KELKAR & CO. Mar-23 |
TATVA CHINTAN PHARMA Mar-23 |
S H KELKAR & CO./ TATVA CHINTAN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 167 | 2,649 | 6.3% | |
Low | Rs | 82 | 1,606 | 5.1% | |
Sales per share (Unadj.) | Rs | 121.8 | 191.1 | 63.8% | |
Earnings per share (Unadj.) | Rs | 4.5 | 20.5 | 22.2% | |
Cash flow per share (Unadj.) | Rs | 10.4 | 24.8 | 41.7% | |
Dividends per share (Unadj.) | Rs | 2.00 | 2.00 | 100.0% | |
Avg Dividend yield | % | 1.6 | 0.1 | 1,713.0% | |
Book value per share (Unadj.) | Rs | 76.9 | 232.2 | 33.1% | |
Shares outstanding (eoy) | m | 138.42 | 22.17 | 624.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.0 | 11.1 | 9.2% | |
Avg P/E ratio | x | 27.3 | 103.7 | 26.3% | |
P/CF ratio (eoy) | x | 12.0 | 85.7 | 14.0% | |
Price / Book Value ratio | x | 1.6 | 9.2 | 17.6% | |
Dividend payout | % | 44.0 | 9.7 | 451.3% | |
Avg Mkt Cap | Rs m | 17,192 | 47,157 | 36.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,118 | 386 | 548.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 16,865 | 4,236 | 398.1% | |
Other income | Rs m | 166 | 57 | 289.7% | |
Total revenues | Rs m | 17,032 | 4,294 | 396.7% | |
Gross profit | Rs m | 1,921 | 572 | 335.8% | |
Depreciation | Rs m | 805 | 96 | 842.0% | |
Interest | Rs m | 239 | 86 | 277.8% | |
Profit before tax | Rs m | 1,044 | 448 | 233.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 414 | -7 | -5,848.9% | |
Profit after tax | Rs m | 630 | 455 | 138.4% | |
Gross profit margin | % | 11.4 | 13.5 | 84.4% | |
Effective tax rate | % | 39.7 | -1.6 | -2,509.6% | |
Net profit margin | % | 3.7 | 10.7 | 34.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 12,065 | 3,136 | 384.8% | |
Current liabilities | Rs m | 7,087 | 2,361 | 300.1% | |
Net working cap to sales | % | 29.5 | 18.3 | 161.5% | |
Current ratio | x | 1.7 | 1.3 | 128.2% | |
Inventory Days | Days | 17 | 3 | 576.9% | |
Debtors Days | Days | 9 | 73 | 13.0% | |
Net fixed assets | Rs m | 9,953 | 4,304 | 231.3% | |
Share capital | Rs m | 1,384 | 222 | 624.5% | |
"Free" reserves | Rs m | 9,260 | 4,926 | 188.0% | |
Net worth | Rs m | 10,644 | 5,148 | 206.8% | |
Long term debt | Rs m | 3,189 | 42 | 7,538.8% | |
Total assets | Rs m | 22,018 | 7,439 | 296.0% | |
Interest coverage | x | 5.4 | 6.2 | 86.5% | |
Debt to equity ratio | x | 0.3 | 0 | 3,646.2% | |
Sales to assets ratio | x | 0.8 | 0.6 | 134.5% | |
Return on assets | % | 3.9 | 7.3 | 54.2% | |
Return on equity | % | 5.9 | 8.8 | 66.9% | |
Return on capital | % | 9.3 | 10.3 | 90.1% | |
Exports to sales | % | 4.7 | 76.2 | 6.2% | |
Imports to sales | % | 10.9 | 56.9 | 19.1% | |
Exports (fob) | Rs m | 795 | 3,229 | 24.6% | |
Imports (cif) | Rs m | 1,835 | 2,409 | 76.2% | |
Fx inflow | Rs m | 795 | 3,229 | 24.6% | |
Fx outflow | Rs m | 1,835 | 2,409 | 76.2% | |
Net fx | Rs m | -1,041 | 820 | -126.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,967 | 278 | 707.9% | |
From Investments | Rs m | -1,029 | -1,011 | 101.8% | |
From Financial Activity | Rs m | -1,748 | 378 | -462.6% | |
Net Cashflow | Rs m | -882 | -357 | 247.3% |
Indian Promoters | % | 48.2 | 72.0 | 66.9% | |
Foreign collaborators | % | 10.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 9.1 | 16.5 | 55.4% | |
FIIs | % | 8.9 | 3.7 | 242.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 41.1 | 28.0 | 146.7% | |
Shareholders | 46,379 | 73,730 | 62.9% | ||
Pledged promoter(s) holding | % | 7.5 | 0.0 | - |
Compare S H KELKAR & CO. With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES GHCL
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | S H KELKAR & CO. | TATVA CHINTAN PHARMA |
---|---|---|
1-Day | -1.53% | 0.02% |
1-Month | -0.27% | 9.97% |
1-Year | 80.70% | -23.68% |
3-Year CAGR | 16.38% | -18.73% |
5-Year CAGR | 7.22% | -11.70% |
* Compound Annual Growth Rate
Here are more details on the S H KELKAR & CO. share price and the TATVA CHINTAN PHARMA share price.
Moving on to shareholding structures...
The promoters of S H KELKAR & CO. hold a 59.0% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of S H KELKAR & CO. and the shareholding pattern of TATVA CHINTAN PHARMA.
Finally, a word on dividends...
In the most recent financial year, S H KELKAR & CO. paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 44.0%.
TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.
You may visit here to review the dividend history of S H KELKAR & CO., and the dividend history of TATVA CHINTAN PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.